Federal grants to Window Therapeutics, Inc.
Window Therapeutics, Inc. in Dorchester, Massachusetts received $1.6 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Technology, Innovation, and Partnerships, with $1.0 million. In fiscal 2025 it was awarded $1.0 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$1.6 million
- Awards3
- Awarded in FY 2025$1.0 million
- Largest award$1.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 1 | $256,000 |
| FY 2023 | 1 | $299,999 |
| FY 2024 | 0 | $0 |
| FY 2025 | 1 | $1.0 million |
Programs that fund Window Therapeutics, Inc.
| Program | Awards | Amount |
|---|---|---|
| Technology, Innovation, and Partnerships | 1 | $1.0 million |
| Cancer Treatment Research | 1 | $299,999 |
| Engineering | 1 | $256,000 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| National Science Foundation | 2 | $1.3 million |
| Department of Health and Human Services | 1 | $299,999 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Sbir phase II: antibody-drug conjugates (ADCS) with high drug-antibody ratios (DAR) and molecularly targeted payloads -the broader/commercial impact of this small business innovation research (SBIR) phase II project is to significantly extend the life expectancy of the many americans who suffer from | Technology, Innovation, and Partnerships | July 9, 2025 | $1.0 million |
| Proteasome inhibitor-loaded antibody drug conjugates with high drug loading for targeted treatment of triple negative breast cancers - project summary/abstract proteasome inhibitors (PIS) are one of the most important classes of therapeutics to have emerged in the past two decades and now serve as t | Cancer Treatment Research | September 15, 2023 | $299,999 |
| Sbir phase i: antibody brush polymer conjugates with high drug antibody ratios and immunostimulatory payloads for treatment of late-stage cancers -the broader impact/commercial potential of this small business innovation research (SBIR) phase i project is to make a new class of antibody-based immuno | Engineering | February 24, 2022 | $256,000 |
Questions people ask
How much federal grant money does Window Therapeutics, Inc. get?
$1.6 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Window Therapeutics, Inc. the most?
The National Science Foundation, with $1.3 million in 2 awards. The Department of Health and Human Services follow.
What is Window Therapeutics, Inc.'s largest federal grant?
$1.0 million under Technology, Innovation, and Partnerships, with its first action in the period on July 9, 2025. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Window Therapeutics, Inc.?
Its largest are Technology, Innovation, and Partnerships, Cancer Treatment Research and Engineering.
Other grant recipients in Dorchester
- University of Mass at Boston
- Harbor Health Services, Inc.
- Dothouse Health, Inc.
- Harvard Street Neighborhood Health Center Inc
- Uphams Corner Health Committee, Inc.
- Massachusetts Historical Society
- Adeptrix Corp
- Secretary of Commonwealth Massachusetts
Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts